Lumos Pharma, Inc. Profile Avatar - Palmy Investing

Lumos Pharma, Inc.

Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for rare diseases. Its lead therapeutic candidate LUM-201 is an oral growth hormone secretagogue ibutamoren, which is in Phas…

Biotechnology
US, Austin [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group

Peers Performance

A quick analysis that compared Lumos Pharma, Inc. (LUMO) to it's peer group.

Peer Group
STTK RZLT ZIVO CSBR ELYM AMTI SILO ERAS ANEB FBRX IPSC PRDS THRX Compare Together
Loading...
End of LUMO's Analysis
CIK: 1126234 CUSIP: 55028X109 ISIN: US55028X1090 LEI: - UEI: -
Secondary Listings
LUMO has no secondary listings inside our databases.